Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam-Reference-Cited by-同舟云学术

Mycology laboratory diagnostic capacity for invasive fungal diseases in public hospitals in Vietnam

Published:2024-08 Issue:8 Volume:62 Page:
ISSN:1369-3786
Container-title:Medical Mycology
language:en
Short-container-title:

Author:

Hieu Vu Ngoc¹²^ORCID,Hiep Nguyen Le³,Hang Le Minh⁴⁵,Lau-Goodchild Bianca A⁶,Van Duong Nguyen⁷,Linh Nguyen Thuy⁸,Beardsley Justin⁵^ORCID,Dat Vu Quoc⁵⁹^ORCID

Affiliation:

1. Department of Microbiology, Hanoi Medical University , Hanoi , Vietnam

2. Hanoi Medical University Hospital, Hanoi Medical University , Hanoi , Vietnam

3. Hanoi University of Pharmacy , Hanoi , Vietnam

4. Woolcock Institute of Medical Research , Hanoi , Vietnam

5. Sydney Infectious Diseases Institute (Sydney ID), The University of Sydney , Darlington, NSW , Australia

6. Sydney School of Public Health, The University of Sydney , Camperdown, NSW , Australia

7. Thanh Hoa Lung Hospital , Thanh Hoa , Vietnam

8. Department of Administration, Hanoi Medical University , Hanoi , Vietnam

9. Department of Infectious Diseases, Hanoi Medical University , Hanoi , Vietnam

Abstract

Abstract This was a cross-sectional study on the availability of laboratory infrastructure and capacity for the diagnosis of invasive fungal diseases in 24 public hospitals in Vietnam in 2023. Among the hospitals surveyed, 66.7% (14/21) had specialized personnel assigned for mycology testing, and 95.8% (23/24) had a separate microbiology laboratory space. Microscopy and culture methods are available in nearly all laboratories for isolate identification. Antifungal susceptibility testing is only performed for yeasts in 16/24 (66.7%) laboratories. Non-culture methods are hardly used in laboratories. Strengthening local laboratory capacities is essential to meeting health needs in these endemic regions.

Funder

Pfizer

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/mmy/advance-article-pdf/doi/10.1093/mmy/myae082/58790394/myae082.pdf

Reference15 articles.

1. Global incidence and mortality of severe fungal disease;Denning;Lancet Infect Dis,2024

2. Antifungal drugs;Houšť;Metabolites,2020

3. Diagnostic mycology laboratories should have a central role for the management of fungal disease;Medina;J Fungi,2022

4. The current state of laboratory mycology in Asia/Pacific: a survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM);Salmanton-García;Int J Antimicrob Agents,2023

5. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: an Asia Fungal Working Group (AFWG) initiative;Chindamporn;Med Mycol,2018